Global Intrauterine Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product Type;
Hormonal Intrauterine Device and Copper Intrauterine Device.By End User;
Hospitals, Clinics, Community Health Care Centres, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Intrauterine Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Intrauterine Devices Market was valued at USD 4,165.33 million. The size of this market is expected to increase to USD 6,910.48 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.5%.
The Global Intrauterine Devices (IUDs) Market comprises a diverse range of contraceptive devices designed for long-term, reversible birth control. These devices are inserted into the uterus and offer highly effective contraception by preventing sperm from fertilizing the egg or by altering the uterine environment. The market is driven by factors such as increasing awareness about family planning, rising prevalence of unintended pregnancies, and growing demand for safe and reliable contraceptive methods.
One of the primary drivers of market growth is the rising awareness about family planning and the importance of contraception in preventing unintended pregnancies. Governments, healthcare organizations, and advocacy groups are actively promoting family planning initiatives and educational campaigns to increase awareness about contraceptive options, including intrauterine devices. As a result, more women are opting for IUDs as a convenient and effective method of birth control, driving market expansion globally.
The increasing prevalence of unintended pregnancies, particularly in developing countries with limited access to contraception, is driving the demand for intrauterine devices. IUDs offer a highly effective and reversible contraceptive option with long-term protection, making them suitable for women who desire reliable birth control without the need for daily adherence or frequent clinic visits. As governments and healthcare providers focus on reducing unintended pregnancies and improving maternal and child health outcomes, the adoption of IUDs is expected to increase, further fueling market growth.
The growing demand for safe and reliable contraceptive methods, coupled with advancements in IUD technology, is driving innovation and product development in the market. Manufacturers are introducing new IUD models with improved design features, such as smaller insertion devices, hormone-releasing options, and enhanced efficacy and safety profiles. These advancements are expanding the range of options available to women and healthcare providers, driving market growth and increasing the accessibility and acceptability of intrauterine devices as a preferred method of contraception globally.
Global Intrauterine Devices Market Recent Developments
-
In August 2022, Bayer AG received FDA approval for a supplemental new drug application (sNDA) for Mirena IUD, extending its period of use to up to eight years. This approval is intended to ensure that women have access to the contraceptive options needed at various stages of their reproductive life.
-
In January 2024, Medicines360, a global nonprofit in women's health, and DKT WomanCare, a global distributor of contraceptive products, partnered to expand access to AVIBELA. AVIBELA is a cost-effective, high-quality hormonal IUD with over 99% effectiveness.
Segment Analysis
The market for intrauterine devices (IUDs) is primarily divided into two main product types: hormonal intrauterine devices and copper intrauterine devices. Hormonal IUDs release progestin, a hormone that thickens cervical mucus, preventing sperm from reaching an egg and sometimes stopping ovulation. These devices are often favored for their additional benefits, such as reducing menstrual bleeding and providing long-term contraception for up to several years. Copper IUDs, on the other hand, do not contain hormones and instead use copper to create an environment that is toxic to sperm, preventing fertilization. Copper IUDs are a popular choice for women who prefer a non-hormonal option and can remain effective for up to 10 years.
End-users for IUDs include hospitals, clinics, community healthcare centers, and other facilities. Hospitals are typically involved in the more complex cases, including insertion of IUDs in women with specific health considerations or those seeking post-abortion contraception. They provide comprehensive services and follow-up care, including monitoring for potential complications. Clinics, especially family planning and reproductive health clinics, are another significant point of service for IUD insertion, offering more personalized care and counseling about contraception options. These settings are particularly important for women seeking regular or immediate contraceptive solutions.
Community healthcare centers play a critical role in providing affordable and accessible healthcare services, including IUD insertion and education about contraception. These centers are especially important in underserved areas, where access to more specialized healthcare facilities may be limited. Other end-users include private practices, gynecology offices, and reproductive health organizations, all of which provide contraception services tailored to individual needs. With the increasing emphasis on family planning and reproductive health, these end-users are becoming central to improving access to IUDs and educating women about their contraceptive options.
Global Intrauterine Devices Segment Analysis
In this report, the Global Intrauterine Devices Market has been segmented by Product Type, End User, and Geography.
Global Intrauterine Devices Market, Segmentation by Product Type
In this report, the Global Intrauterine Devices Market has been segmented by Product Type into Hormonal intrauterine device and Copper intrauterine device.
Hormonal IUDs release progestin hormones into the uterus, which thicken cervical mucus, inhibit sperm movement, and thin the uterine lining, thereby preventing fertilization and implantation. These devices are highly effective in preventing pregnancy and offer additional benefits such as reduced menstrual bleeding and cramping. They are favored by women seeking long-term contraception with minimal side effects and hormonal regulation. Copper intrauterine devices, also known as non-hormonal or inert IUDs, are made of plastic with copper wire wrapped around the stem or arms. Unlike hormonal IUDs, Cu-IUDs do not contain any hormones and work by releasing copper ions into the uterus, which create an inhospitable environment for sperm, preventing fertilization. Copper IUDs are highly effective, long-lasting, and reversible contraceptive options suitable for women who prefer non-hormonal birth control methods or have contraindications to hormonal contraception. They offer the advantage of immediate fertility restoration upon removal and do not interfere with natural hormonal cycles.
Global Intrauterine Devices Market, Segmentation by End User
In this report, the Global Intrauterine Devices Market has been segmented by End User into Hospitals, Clinics, Community Health Care Centres, and Others.
Clinics are another important end-user for healthcare services and medical devices. These facilities tend to focus on outpatient care, offering services such as routine checkups, diagnostic tests, minor surgeries, and treatments for common illnesses. Clinics often provide specialized services, including reproductive health, dermatology, and general family care. They are typically more accessible than hospitals and serve as primary points of contact for patients seeking preventive care or less complex treatments. Many clinics have adopted innovative medical technologies to enhance patient care and improve service efficiency, particularly in areas like diagnostics and telemedicine.
Community health care centers serve as vital resources for underserved populations, particularly in rural or low-income urban areas. These centers focus on providing affordable, accessible healthcare services, often emphasizing preventative care, maternal and child health, vaccination programs, and basic medical treatments. Community health centers are particularly important for individuals who may not have easy access to hospitals or clinics due to financial or logistical barriers. They are integral in improving public health outcomes by offering health education and preventive services. Other end-users in the healthcare space include private practices, rehabilitation centers, long-term care facilities, and specialized treatment centers, which provide focused care for specific conditions, such as addiction treatment, mental health, or palliative care.
Global Intrauterine Devices Market, Segmentation by Geography
In this report, the Global Intrauterine Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Intrauterine Devices Market Share (%), by Geographical Region, 2024
North America holds a significant share of the global intrauterine devices market, driven by factors such as high awareness about contraceptive options, favorable reimbursement policies, and widespread availability of healthcare services. The region benefits from established family planning programs, comprehensive sex education, and easy access to a wide range of contraceptive methods, including intrauterine devices. Additionally, favorable government initiatives and advocacy efforts promote contraceptive access and choice, further contributing to market growth in North America.
Europe is another prominent market for intrauterine devices, characterized by progressive healthcare policies, high contraceptive prevalence rates, and advanced contraceptive technologies. Countries within the European Union, such as Germany, France, and the United Kingdom, exhibit high levels of contraceptive use and acceptance of long-acting reversible contraceptives like IUDs. Moreover, comprehensive sexual and reproductive health services, along with supportive government policies, contribute to the widespread adoption of intrauterine devices in Europe, driving market expansion across the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Intrauterine Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunities
Drivers:
- Increasing Awareness and Acceptance
- Rising Demand for Non-Hormonal Contraceptives
-
Government Initiatives and Supportive Policies: Government initiatives focused on family planning and reproductive health play a pivotal role in fueling the growth of the intrauterine devices (IUDs) market. By prioritizing initiatives that promote access to contraceptives, governments worldwide are contributing to increased awareness and utilization of IUDs as a reliable birth control option. These initiatives encompass a range of measures, including subsidized or free distribution programs and the integration of IUDs into public health insurance schemes. By making IUDs more affordable and accessible, these policies are breaking down financial barriers and ensuring that a larger segment of the population can benefit from this highly effective contraceptive method.
The inclusion of IUDs in public health insurance schemes further enhances accessibility by reducing out-of-pocket expenses for individuals seeking contraception. This proactive approach not only encourages more women to consider IUDs as a viable contraceptive choice but also promotes overall reproductive health by providing access to a wider range of family planning options. As a result, government support and policy interventions are crucial drivers in expanding the IUD market and improving reproductive healthcare outcomes for communities worldwide.
Restraints:
- Preference for Alternate Contraceptive Methods
- High Initial Cost and Accessibility Issues
-
Potential Complications and Side Effects: While intrauterine devices (IUDs) are widely regarded as safe and highly effective contraceptive options, concerns about potential complications and side effects can influence the decision-making process for some women. Perforation, expulsion, and an increased risk of pelvic inflammatory disease (PID) are among the known risks associated with IUD use. Perforation, though rare, occurs when the device punctures the uterine wall during insertion, while expulsion refers to the unintentional displacement of the IUD from the uterus. Additionally, while IUDs generally reduce the risk of PID, there is a slight increase in risk during the initial period after insertion, particularly in individuals with pre-existing risk factors.
These potential risks, albeit infrequent, can instill apprehension in some women considering IUDs as a contraceptive option, thus impacting market growth. Addressing these concerns requires comprehensive patient education and counseling by healthcare providers to ensure informed decision-making. Moreover, ongoing research and development efforts aimed at enhancing the safety and efficacy of IUDs, along with improvements in insertion techniques and follow-up protocols, can help mitigate perceived risks and bolster confidence in these devices as a reliable long-term contraceptive solution. By addressing concerns and ensuring appropriate risk management strategies, the IUD market can continue to expand, offering women a broader range of contraceptive choices tailored to their individual needs and preferences.
Opportunities:
- Technological Advancements and Product Innovation
- Expanding Market in Developing Regions
-
Rising Female Empowerment and Education: As female empowerment and educational attainment levels rise globally, women are increasingly asserting control over their reproductive health decisions. With greater access to education and information, women are becoming more proactive in exploring contraceptive options that best align with their lifestyle, preferences, and reproductive goals. This heightened awareness and autonomy in decision-making are key drivers fueling the demand for intrauterine devices (IUDs), particularly among those seeking reliable, long-term contraception solutions.
Education plays a crucial role in empowering women to make informed choices about their reproductive health, including contraceptive methods. As women gain a better understanding of the benefits and efficacy of IUDs, they are more likely to consider them as a preferred option for birth control. Furthermore, the autonomy to make decisions about contraceptive use without external pressures or constraints empowers women to select the method that best suits their individual needs and circumstances. As a result, the growing emphasis on female empowerment and education worldwide is expected to continue driving the demand for IUDs, contributing to their increasing adoption rates and market growth.
Competitive Landscape Analysis
Key players in Global Intrauterine Devices Market include
- Actavis
- Bayer
- Teva Pharmaceutical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Intrauterine Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Awareness and Acceptance
- Rising Demand for Non-Hormonal Contraceptives
- Government Initiatives and Supportive Policies
- Restraints
- Preference for Alternate Contraceptive Methods
- High Initial Cost and Accessibility Issues
- Potential Complications and Side Effects
- Opportunities
- Technological Advancements and Product Innovation
- Expanding Market in Developing Regions
- Rising Female Empowerment and Education
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Intrauterine Devices Market, By Product Type, 2021 - 2031 (USD Million)
- Hormonal intrauterine device
- Copper intrauterine device
- Global Intrauterine Devices Market, By End Use, 2021 - 2031 (USD Million)
- Hospitals
- Clinics
- Community Health Care Centres
- Others
- Global Intrauterine Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Intrauterine Devices Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Actavis
- Bayer
- Teva Pharmaceutical
- Company Profiles
- Analyst Views
- Future Outlook of the Market